Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences


Featured Articles

Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies

James Barry, Director of Marketing, Americas, Pall Biotech

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules

Overcoming Obstacles in AAV Viral Vector Manufacturing

View All Featured Articles

Headline News

Robigo raises Series A led by Leaps by Bayer to advance engineered crop protection biologicals


FDA approves Kerendia for chronic kidney disease linked to type 1 diabetes


FDA approves Lilly’s once weekly Onswik insulin for adults with type 2 diabetes


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

The Journey Of Implementing Advanced Process Control In the Pharmaceutical Industry

Presented by Olav Lyngberg, PhD, Sr. Scientific Fellow, Advanced Technology Center of Excellence, Technical Operations, Janssen Pharmaceuticals and Mark Demesmaeker, Head of Data Analytics at Sartorius Stedim Biotech
16th March 2020


Holistic Approach to the Industry 4.0 Investment Breaking Down the Fences Between R&D & Manufacturing

Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Shilpa Nargund, Director at Insilico Biotechnology Pte. Ltd., Singapore
14th March 2022


Next Generation Bioprocess Facility Design – A Case Study From Samsung Biologics

Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics and John Bonham-Carter. Product Line Leader, Cell Culture & Clarification Business, Repligen
26th October 2020


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia